Kurin® Blood Culture Collection Set
with the patented, FDA 510(k) cleared Kurin Lock™ specimen diversion device
IntroducingKurin Lock™ Technology
Most blood culture
contaminants come from patient’s skin
Sideline contaminantsin the initial blood flow
Kurin Lock TechnologyReshaping Blood Culture Collection
News
- Not Your “Average” ED: A CNS-Led Project That Reduced Blood Culture Contaminations in One Emergency Department to Below Expected Levels
- Kurin, Inc. Receives Allowance from United States Patent and Trademark Office for Patent on Innovative Blood Culture Collection Device
{"ticker_effect":"slide-h","autoplay":"true","speed":"4000","font_style":"normal"}
A typical blood culture collection set provides skin microbes a direct line to the culture bottle, but not Kurin.
Seamlessly integrated into familiar blood culture collection sets, the Kurin Lock specimen diversion device addresses the skin contaminants that challenge hospital efforts to reduce false-positive blood cultures.
Standing guard between the venipuncture site and the culture bottle, the Kurin Lock diverts the initial blood specimen that may contain skin microbes from deep within the dermis. A clinically-relevant specimen then bypasses the contaminants locked within the device.
The problem with false-positive blood cultures
Determining whether a bloodstream infection exists is critical to the wellbeing of patients and the financial health of hospitals.
A blood culture test is the gold standard for identifying bacteremia.
Each year, millions of blood culture tests inform patient care decisions in the U.S. The majority will find no infection.1 But, of the cultures that test positive, almost 1/3 are false-positive results.
When blood cultures test positive—whether true or false—immediate action is taken to treat the patient with antibiotic therapy.
Roughly 20% of the microbes present in skin reside deep in the dermis layer and may be drawn into blood samples.2 Without a way to avoid these microbes, hospitals have accepted high rates of seemingly unavoidable false positives—until now with the introduction of Kurin.
REFERENCES:
1 Zwang O, Albert RK. Analysis of Strategies to Improve Cost Effectiveness of Blood Cultures. J Hosp Med. 2006 Sep;1(5):272-6.
2 Garcia RA, Spitzer ED, Beaudry J, et al. Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremia, reducing contamination, and eliminating false-positive central line-associated bloodstream infections. Am J Infect Control. 2015 Nov 1;43(11):1222-37.
From the creators of Curos™ Port Protectors
Curos is a registered trademark of 3M
Contact Us
Kurin®, Inc.
10755 Scripps Poway Parkway, Suite 257
San Diego, CA 92131
1-888-963-9056
Email Us
Kurin Brochure
About Us
Copyright © 2018 Kurin Inc. All rights reserved.